Lonza Group AG
/ Key word(s): Bond/Financing
Basel, Switzerland, 17 April 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a EUR 1 billion straight bond. The Eurobond marks Lonza’s second drawdown under its EMTN program. The bond has a maturity of 12 years and an annual coupon of 3.875%. The issuer is Lonza Finance International NV and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the Luxembourg Stock Exchange (Regulated Market). The proceeds of the bonds will be used for refinancing and general corporate purposes. Lonza’s issuer rating is currently BBB+ (S&P Global Ratings) with a stable outlook. A consortium comprising of BNP Paribas, BofA, Goldman Sachs, ING, JP Morgan and Mizuo were mandated to place the bond as Joint Active Bookrunners.
Key Data Issue Size 12-Year Bond: EUR 1 billion Expected Payment Date: 24 April 2024 Maturity: 24 April 2036 Issue Price: 98.715 percent Redemption Price: 100 percent Coupon: 3.875 percent p.a. About Lonza Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients. Our company generated sales of CHF 6.7 billion with a CORE EBITDA of CHF 2.0 billion in Full-Year 2023. Find out more at Follow @Lonza on Lonza Contact Details Victoria Morgan Daniel Buchta Additional Information and Disclaimer Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release. All trademarks belong to Lonza and are registered in CH, US and/or EU, or belong to their respective third-party owners and are used only for informational purposes. Privacy Policy
End of Media Release |
Language: | English |
Company: | Lonza Group AG |
Münchensteinerstrasse 38 | |
4052 Basel | |
Switzerland | |
Phone: | |
Internet: | |
ISIN: | CH0013841017 |
Valor: | 1384101 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1883085 |
End of News | EQS News Service |
|
1883085 17.04.2024 CET/CEST